Caution in metastatic renal cell carcinoma within lymph nodes: PAX-2 expression is also seen in nodal lymphocytes

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 4, 2011, Pages 414-415

  Truong, Luan ^a   Ozcan, Ayhan ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PAX2 PROTEIN, HUMAN; PAX5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX5; TUMOR MARKER;

CASE REPORT; CROSS REACTION; DIAGNOSTIC ERROR; FEMALE; HUMAN; IMMUNOLOGY; KIDNEY CARCINOMA; KIDNEY TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOCYTE; MALE; METABOLISM; METASTASIS; NOTE; PATHOLOGY;

B-CELL-SPECIFIC ACTIVATOR PROTEIN; CARCINOMA, RENAL CELL; CROSS REACTIONS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; PAX2 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 79955096379     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Ozcan A, Zhai QJ, Javed R, et al. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific Cadherin. Arch Pathol Lab Med. 2010; 134(8): 1121-1129.
2. Zhai QJ, Ozcan A, Hamilton C, et al. PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol. 2010;18(4):323-332.